CVS Financial Facts
Operating expenses: 4.68BNet loss attributable to noncontrolling interest: -1M
See Full Income Statement
Total liabilities and shareholders' equity: 94.16B
Claims and discounts payable: 9.18B
See Full Balance Sheet
CVS Caremark Corporation (CVS) Earnings
|
Expand Research on CVS
| Next EPS Date | 7/31/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +21.7% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/26  |
Q126 | N/A | $2.23 | N/A | N/A | $95.86B | = | N/A | N/A | ||
| 2/10/26 | Q425 | $1.09 | $1.00 | +$0.09 | $105.7B | $103.63B | = |  | | Details | |
| 10/29/25 | Q325 | $1.60 | $1.37 | +$0.23 | $102.9B | $98.88B | = | | | Details | |
| 7/31/25 | Q225 | $1.81 | $1.46 | +$0.35 | $98.9B | $94.73B | = | | | Details | |
| 5/1/25 | Q125 | $2.25 | $1.64 | +$0.61 | $94.6B | $93.07B | = | | | Details | |
| 2/12/25 | Q424 | $1.19 | $1.00 | +$0.19 | $97.7B | $96.97B | = | | | Details | |
| 11/6/24 | Q324 | $1.09 | $1.55 | -$0.46 | $95.4B | $92.7B |  |
| | Details | |
| 8/7/24 | Q224 | $1.83 | $1.73 | +$0.10 | $91.2B | $91.43B | |
| | Details |
